Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing rifabutin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |
Rifabutin adverse reaction |
Causative agent (attribute) |
True |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |
Allergy to rifabutin |
Causative agent (attribute) |
False |
Rifabutin (substance) |
Inferred relationship |
Some |
|
Rifabutin 150 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rifabutin (substance) |
Inferred relationship |
Some |
|
Rifabutin-induced anterior uveitis (disorder) |
Causative agent (attribute) |
False |
Rifabutin (substance) |
Inferred relationship |
Some |
2 |
Allergy to rifabutin |
Causative agent (attribute) |
True |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |
Rifabutin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |
Rifabutin 150 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |
Rifabutin 150 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |
Rifabutin 150 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |
Rifabutin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |
Product containing only rifabutin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |
Product containing amoxicillin and omeprazole and rifabutin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |
Amoxicillin and omeprazole and rifabutin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |
Amoxicillin- and omeprazole- and rifabutin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |
Amoxicillin and omeprazole and rifabutin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |
Rifabutin-induced anterior uveitis (disorder) |
Causative agent (attribute) |
True |
Rifabutin (substance) |
Inferred relationship |
Some |
1 |